According to The Insight Partners, the cell therapy bioprocessing market size is expected to reach US$ 64.61 billion by 2034 from US$ 20.74 billion in 2025. The market is anticipated to register a robust Compound Annual Growth Rate (CAGR) of 13.49% during the forecast period of 2026–2034. This strong expansion reflects increasing investments in cell therapy research, growing demand for personalized and regenerative medicine, and the need for advanced manufacturing platforms capable of producing complex biological therapies at commercial scale.
As cell therapies move from experimental applications toward broader clinical and commercial use, manufacturers are focusing on improving process efficiency, scalability, quality control, and cost management. The integration of automation, single-use technologies, advanced analytics, and closed processing workflows is expected to remain important for the industry’s development.
Download Sample PDF – https://www.theinsightpartners.com/sample/TIPRE00021550
Cell Therapy Bioprocessing Market Size, Share, Trends, Analysis, and Forecast to 2034
- Market Size: The global market is projected to increase from US$ 20.74 billion in 2025 to US$ 64.61 billion by 2034.
- Market Growth: The market is expected to expand at a 13.49% CAGR from 2026 to 2034.
- Market Share: North America is a key contributor to the market, supported by its established biotechnology industry, advanced healthcare infrastructure, and strong cell therapy development pipeline.
- Technology Trends: Increasing adoption of single-use bioprocessing systems, automated manufacturing, closed-system processing, and real-time process monitoring is transforming cell therapy production.
- Manufacturing Trend: Developers are increasingly seeking scalable and standardized manufacturing processes to support the transition from clinical development to commercial production.
- Personalized Medicine: Growing demand for personalized therapies is increasing the need for flexible bioprocessing platforms capable of handling patient-specific cellular materials.
- Outsourcing Trend: The expansion of contract development and manufacturing organizations is enabling biotechnology companies to access specialized cell therapy manufacturing capabilities without establishing extensive in-house infrastructure.
- Product Development: Advances in cell expansion, cell culture media, bioreactors, filtration, cryopreservation, and downstream processing are creating opportunities for technology providers.
- Forecast Outlook: With a projected value of US$ 64.61 billion by 2034, the industry is positioned for sustained expansion as cell-based therapies gain wider clinical and commercial acceptance.
Regional Analysis
North America: North America is expected to remain a prominent region due to substantial investment in biotechnology, a mature pharmaceutical industry, advanced research infrastructure, and a strong pipeline of cell-based therapies. The US is the principal contributor, while Canada is also strengthening its capabilities in regenerative medicine and advanced therapeutic manufacturing.
Europe: Europe represents another important market, supported by increasing research into cell therapies, established pharmaceutical and biotechnology companies, and efforts to develop advanced manufacturing capabilities. Growing investments in regenerative medicine and innovative healthcare technologies are expected to create additional opportunities.
Asia Pacific: Asia Pacific is anticipated to witness considerable growth during the forecast period. Expanding biotechnology industries, increasing healthcare investments, rising research activities, and growing interest in advanced therapies in countries such as China, Japan, South Korea, and India are supporting regional development.
Middle East & Africa: The Middle East & Africa market is developing as healthcare infrastructure improves and governments increase investments in advanced medical technologies and biotechnology. Increasing awareness of innovative therapies is expected to gradually support demand for cell therapy bioprocessing solutions.
South & Central America: The region is expected to experience steady development as healthcare systems expand, biotechnology research increases, and interest in advanced therapeutic approaches grows. Brazil and other major markets are likely to contribute to regional opportunities.
Key Market Trends and Growth Drivers
The increasing prevalence of chronic diseases and the growing demand for innovative treatment approaches are important factors supporting cell therapy development. Cell therapies offer the potential to address diseases that have limited treatment options, creating significant interest among researchers and pharmaceutical companies. As the number of cell therapy candidates advances through clinical development, manufacturers require bioprocessing platforms that can provide consistent quality and reproducible output.
Another important trend is the shift toward automation and closed manufacturing systems. Automated platforms can reduce manual intervention, improve process control, and enhance manufacturing consistency. Single-use technologies are also gaining attention because they can simplify facility operations, reduce cleaning requirements, and potentially accelerate production changeovers. Furthermore, improvements in analytical technologies are enabling manufacturers to monitor critical process parameters and product quality more effectively.
The industry is also experiencing increasing emphasis on scalable manufacturing and cost optimization. Cell therapies can involve complex production workflows, making manufacturing efficiency a critical consideration. Companies are therefore investing in integrated technologies designed to streamline cell processing from initial collection through expansion, harvesting, formulation, and storage.
Key Players
The competitive landscape includes established life sciences, biotechnology, and bioprocessing companies offering technologies, equipment, consumables, and manufacturing solutions for cell therapy applications.
- Fresenius Kabi AG
- Asahi Kasei Corporation
- Sartorius AG
- MERCK KGaA
- THERMO FISHER SCIENTIFIC INC.
- Corning Incorporated
- Cytiva
- Lonza
- Repligen
- Catalent Inc
These companies are focusing on technological innovation, product development, strategic collaborations, manufacturing expansion, and integrated bioprocessing solutions to address the evolving requirements of cell therapy developers.
Get Premium Market Research Report Here: https://www.theinsightpartners.com/buy/TIPRE00021550
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish
